The global Antisense Oligonucleotide (ASO) for Cardiometabolic Disorders Market focuses on a pioneering class of drugs designed to silence or modulate the function of specific genes that cause disease. These synthetic nucleic acid sequences are engineered to address the underlying genetic drivers of complex conditions such as severe dyslipidemia (high cholesterol/triglycerides), heart... https://www.databridgemarketresearch.com/